Stockscreener 앱 받기
0.6709
7.39%
0.0319
전일 마감가:
$0.639
열려 있는:
$0.64
하루 거래량:
283.37K
Relative Volume:
0.07
시가총액:
$2.40M
수익:
-
순이익/손실:
$-13.28M
주가수익비율:
-0.1461
EPS:
-4.5911
순현금흐름:
$-8.99M
1주 성능:
-28.52%
1개월 성능:
-48.01%
6개월 성능:
-87.26%
1년 성능:
-99.25%
1일 변동 폭
$0.6299
$0.6997
1주일 범위
$0.6221
$0.90
52주 변동 폭
$0.3015
$106.32
Gri Bio Inc Stock (GRI) Company Profile
명칭
Gri Bio Inc
전화
(619) 400-1171
주소
2223 AVENIDA DE LA PLAYA, LA JOLLA
GRI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| GRI | 0.6709 | 2.40M | 0 | -13.28M | -8.99M | -4.5911 |
| VRTX | 449.47 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.00 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 594.28 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 245.84 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.00 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Gri Bio Inc 주식(GRI)의 최신 뉴스
GRI Bio reports progress in IPF treatment with GRI-0621 - Investing.com
GRI Bio Showcases GRI-0621’s Potential to Reduce - GlobeNewswire
GRI Bio's IPF Drug Shows Promise in Preclinical Data, Phase 2a Trial Underway | GRI Stock News - StockTitan
GRI Bio files to sell 1.58M shares of common stock for holders - MSN
SEC Form 424B3 filed by GRI Bio Inc. - Quantisnow
GRI Bio Inc (GRI) Quarterly 10-Q Report - Quartzy
GRI Bio Reports Third Quarter 2024 Financial Results and - GlobeNewswire
GRI Bio Raises $13.9M, Extends Runway for Key IPF Drug Trial Data in 2025 | GRI Stock News - StockTitan
GRI Bio Inc expected to post a loss of 73 cents a shareEarnings Preview - XM
Ascendiant Capital Initiates Coverage of GRI Bio (GRI) with Buy Recommendation - MSN
Curis (CRIS) Stock Plummets Over 5% Amid Lack of Institutional R - GuruFocus.com
Primary Sclerosing Cholangitis Pipeline 2024: Clinical Trials - openPR
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN
GRI Bio secures funding to advance IPF treatment into 2025 - Investing.com India
GRI Bio secures funding to advance IPF treatment into 2025 By Investing.com - Investing.com UK
GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024 - GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Dow Falls Over 150 Points; General Motors Tops Q3 Views - Benzinga
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN
GRI Bio Announces Exercise of Warrants - GlobeNewswire
Dyne Therapeutics (DYN) Shares Plummet Amid Market Volatility - GuruFocus.com
Top Innovation Stocks Surge: PRSO, SYTA, SAVE, ISPC, GRI, BIVIMust-Watch Stocks This Week - openPR
Energy storage ‘key’ to sustainability – report - Yahoo! Voices
As iPhone Sales Soar in China, Is It Time to Buy Apple Stock? - Yahoo! Voices
2 Artificial Intelligence (AI) Stocks That Are No-Brainer Buys - Yahoo! Voices
Statkraft seeks approval for 2.1GW offshore wind farm in Baltic Sea - Yahoo! Voices
BioPorto A/S Announces Changes to the US Commercial Organization - Yahoo Finance
CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs - Yahoo Finance
bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement - Yahoo Finance
Health Canada approves Arcutis’ ZORYVE foam for seborrheic dermatitis - Yahoo! Voices
Amcor reports 9% drop in greenhouse gas emissions in 2024 - Yahoo! Voices
Esso Australia completes Kipper Compression Project - Yahoo! Voices
Final countdown: 7 days until TechCrunch Disrupt 2024 kicks off - Yahoo! Voices
Cigna and Humana re-engage in merger talks - Yahoo! Voices
Starr Insurance to operate in Seoul, South Korea - Yahoo! Voices
Alliance Group gets insurance intermediary licence in Germany - Yahoo! Voices
PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Live Oak Ventures Participates in Financing of Synply, Inc. - Yahoo Finance
US Stocks Edge Lower; Dow Falls 50 Points - Benzinga
T-Mobile partnership has this beaten down stock launching 🚀 - RagingBull
2 Artificial Intelligence (AI) Stocks That Could Make You a Millionaire - Yahoo! Voices
Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year? - Yahoo Finance
Company News for Oct 21, 2024 - Yahoo Finance
Stock market today: Nasdaq leads stocks lower in wait for earnings to rush in, 10-yr yield climbs to July high - Yahoo
Harris raises more than $220 million in September, outraising Trump 3-to-1 - Yahoo! Voices
ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 - Yahoo Finance
3 Artificial Intelligence Stocks No One Is Talking About but They Should Be - Yahoo! Voices
JOB ALERT: Goodwill Industries of East Texas needs a supervisor in their south Tyler store - Yahoo News
Is Microsoft Going to $505? 1 Wall Street Analyst Thinks So - Yahoo! Voices
Netflix's Third-Quarter Results Exceeded Expectations. But Is the Stock a Buy? - Yahoo! Voices
Gri Bio Inc (GRI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.80%
0.42%
자본화:
|
볼륨(24시간):